The Global Orally Disintegrating Tablet (ODT) Market is expected to exceed more than US$ 23.89 Billion
![ORALLY DISINTEGRATING TABLETS - Designed With Patients in Mind: The Art of Patient-Centric Drug Formulation ORALLY DISINTEGRATING TABLETS - Designed With Patients in Mind: The Art of Patient-Centric Drug Formulation](https://drug-dev.com/wp-content/uploads/uploads/Public/Images/0ODT/F3.jpg)
ORALLY DISINTEGRATING TABLETS - Designed With Patients in Mind: The Art of Patient-Centric Drug Formulation
![Pfizer Recalls Nurtec ODT Prescription Drugs Due to Failure to Meet Child Resistant Packaging Requirement; Risk of Poisoning | CPSC.gov Pfizer Recalls Nurtec ODT Prescription Drugs Due to Failure to Meet Child Resistant Packaging Requirement; Risk of Poisoning | CPSC.gov](https://www.cpsc.gov/s3fs-public/styles/recall_product/public/RecalledNurtecODTrimegepantorallydisintegratingtabletsblisterpackaging.jpg?VersionId=8SQM4rDaOZtbMlBlSLL66_5rPCl79Kgj&itok=8TIuFS9e)
Pfizer Recalls Nurtec ODT Prescription Drugs Due to Failure to Meet Child Resistant Packaging Requirement; Risk of Poisoning | CPSC.gov
![Apremig ODT | 75 mg | Tablet | ACI Limited | Indications, Pharmacology, Dosage, Side Effects and more | MedEx Apremig ODT | 75 mg | Tablet | ACI Limited | Indications, Pharmacology, Dosage, Side Effects and more | MedEx](https://medex.com.bd/storage/images/packaging/apremig-odt-75-mg-tablet-26788505625-i1-I6b4cUoyga9axl82bXHc.webp)